Parkinson's Disease Flashcards

1
Q

PD epidemiology

A

0.3% prevalence in general population
effects more males than females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

parkinsonism

A

bradykinesia
rigidity
rest tremor
postural instability/gait disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

essential tremor

A

most common movement disorder
autosomal dominant
tremor absent at rest, persists during movement
usually attenuated by alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does a dopamine transport scan do?

A

visualize PD pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pathogenesis of PD

A

aggregation of alpha-synuclein: disrupts lysosomal membrane and creates Lewy bodies
prion-like cell to cell spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pathophysiology of PD

A

many mechanisms: mitochondrial dysfunction, decrease in protein degradation, apoptosis, synaptic pathobiology, calcium homeostasis, neuroinflammation, alpha-synuclein pathology
all lead to cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

motor symptoms of PD

A

due to loss of nigrostriatal dopamine neurons
dopamine deficiency
at time of diagnosis: patients have 40% of normal DA neuron number

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

treatment of PD motor symptoms

A

levodopa: becomes DA in the brain
DA agonists: imitates DA
MAO-B inhibitors: reduces breakdown of DA
DBS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

non-motor PD symptoms

A

due to deficiencies in DA, NE, 5HT, ACh
cognitive, psychiatric, visual, autonomic, sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

types of cognitive/mental PD symptoms

A

executive functions: planning, decision making, judgement, flexibility, multitasking
attention
visuospatial perception
memory
language

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

stages of cognitive impairment in PD

A

mild: can still function and live independently, occurs in more than 50% of patients
dementia: impairment in at least two cognitive domains, significant loss of function affecting independence, occurs in more than 80% of patients who have had the disease for more than 20 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the diagnosis if patients present with cognitive and PD symptoms?

A

dementia with Lewy bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

depression and anxiety in PD

A

common: 50-60% of patients
can be more disabling that motor symptoms
symptoms can fluctuate with medication cycles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

impulse control disorders in PD

A

about 15% prevalence
cumulative incidence of DA agonist medication and impulse control: greatly reduced at discontinuation
pathological gambling, compulsive buying, sexual behaviors, binge eating
risk factors: less than 65 years old, single, smoker, gambling in family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dopamine dysregulation syndrome

A

motor responsiveness to DA medications
addicted to medication
impairment in social or occupational functioning
development of manic reactions to DA medications, withdrawal symptoms if discontinued
seen more often in younger patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

psychosis in PD

A

minor illusions
hallucinations
delusions

17
Q

treatment for non-motor symptoms in PD

A

similar to treatment in general population
avoid medications that can worsen motor symptoms

18
Q

motor fluctuations in PD

A

levodopa effects vary of the course of PD
as time goes on: the therapeutic effect and time decreases while dyskinesia increases
DBS can “reset” the medication course and make levodopa more effective again

19
Q

candidacy for DBS in PD

A

idiopathic: no atypical parkinsonism
disabling and medically refractory motor fluctuations, dyskinesia
preserved responsiveness to dopaminergic medication
no medication or psychiatric disease
no disabling condition
supportive social environment